zxclear

zxclear

[KR-바이오] 07/30 Korea Market Insights

삼성바이오로직스호재 As a senior equity analyst, I evaluate Samsung Biologics’ acquisition of (Polypeptide Group) for approximately KRW 2.7 trillion as a highly strategic and transformative move. This landmark (M&A)—the largest in the history of the Korean biotech industry—enables the company…

[KR-2차전지] 07/29 Korea Market Insights

LG에너지솔루션호재 As a senior equity analyst, I evaluate the recent news regarding LG Energy Solution as a significant catalyst for its non-EV portfolio diversification and North American market dominance. The company has successfully secured a (multi-hundred-billion-won ESS contract) with (Google’s…